Solventum Corp Files 8-K on Financials

TL;DR

Solventum Corp (formerly 3M Health Care) filed an 8-K on Aug 7th detailing financial results.

AI Summary

Solventum Corporation filed an 8-K on August 7, 2025, reporting on its Results of Operations and Financial Condition, and Financial Statements and Exhibits. The company, formerly known as 3M Health Care Co, was incorporated in Delaware and has its principal executive offices at 3M Center, Maplewood, Minnesota. This filing indicates a significant corporate event for Solventum, which was previously a subsidiary of 3M Company.

Why It Matters

This 8-K filing provides crucial updates on Solventum Corporation's financial performance and condition, which is important for investors and stakeholders to assess the company's operational health and future prospects.

Risk Assessment

Risk Level: medium — The filing itself is routine, but the underlying financial performance and any disclosed risks within the full report could significantly impact the company's valuation.

Key Players & Entities

• Solventum Corp (company) — Registrant
• 3M Company (company) — Former parent company
• 3M Health Care Co (company) — Former name
• August 7, 2025 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• Maplewood, Minnesota (location) — Principal executive offices location

FAQ

From the Filing

0001964738-25-000062.txt : 20250807 0001964738-25-000062.hdr.sgml : 20250807 20250807161227 ACCESSION NUMBER: 0001964738-25-000062 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250807 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250807 DATE AS OF CHANGE: 20250807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solventum Corp CENTRAL INDEX KEY: 0001964738 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 922008841 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41968 FILM NUMBER: 251194131 BUSINESS ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 651-733-1110 MAIL ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: 3M Health Care Co DATE OF NAME CHANGE: 20230203 8-K 1 solv-20250807.htm 8-K solv-20250807 FALSE 0001964738 0001964738 2025-08-07 2025-08-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 7, 2025 SOLVENTUM CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware File No. 001-41968 92-2008841 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 3M Center, Building 275-6W 2510 Conway Avenue East , Maplewood , Minnesota 55144 (Address of Principal Executive Offices) (Zip Code) (Registrant’s Telephone Number, Including Area Code) ( 651 ) 733-1110 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $.01 Per Share SOLV New York Stock Exchange Securities registered pursuant to section 12(g) of the Act: None Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company      ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the exchange Act.     ☐ Item 2.02. Results of Operations and Financial Condition On August 7, 2025, Solventum issued a press release reporting second-quarter 2025 financial results (attached hereunder as Exhibit 99.1 and incorporated herein by reference). Item 9.01. Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 99.1 Press Release, dated as of August 7 , 2025, of Solventum Corporation (furnished pursuant to Item 2.02 hereof) 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document). SI